Jensen Investment Management Inc. grew its position in shares of Genpact Limited (NYSE:G - Free Report) by 2.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 195,485 shares of the business services provider's stock after purchasing an additional 5,500 shares during the period. Jensen Investment Management Inc. owned approximately 0.11% of Genpact worth $8,396,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the company. Corient Private Wealth LLC lifted its stake in Genpact by 8.3% during the fourth quarter. Corient Private Wealth LLC now owns 25,599 shares of the business services provider's stock worth $1,099,000 after purchasing an additional 1,966 shares in the last quarter. Globeflex Capital L P raised its stake in shares of Genpact by 75.2% in the fourth quarter. Globeflex Capital L P now owns 203,891 shares of the business services provider's stock valued at $8,757,000 after acquiring an additional 87,504 shares in the last quarter. Swiss National Bank acquired a new stake in shares of Genpact in the fourth quarter valued at $14,298,000. Farther Finance Advisors LLC raised its stake in shares of Genpact by 4.7% in the fourth quarter. Farther Finance Advisors LLC now owns 13,030 shares of the business services provider's stock valued at $560,000 after acquiring an additional 583 shares in the last quarter. Finally, HighTower Advisors LLC raised its stake in shares of Genpact by 112.2% in the fourth quarter. HighTower Advisors LLC now owns 12,573 shares of the business services provider's stock valued at $540,000 after acquiring an additional 6,647 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now directly owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.80% of the company's stock.
Wall Street Analysts Forecast Growth
G has been the topic of several analyst reports. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and increased their price objective for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Mizuho increased their target price on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC raised their price objective on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Finally, Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and raised their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $48.44.
Read Our Latest Stock Report on G
Genpact Price Performance
Shares of Genpact stock traded up $0.22 during trading on Monday, reaching $50.36. The company's stock had a trading volume of 1,136,094 shares, compared to its average volume of 1,307,039. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The company has a market capitalization of $8.85 billion, a P/E ratio of 17.73, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The business has a 50 day moving average price of $49.57 and a 200-day moving average price of $44.30.
Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, sell-side analysts anticipate that Genpact Limited will post 3.21 EPS for the current year.
Genpact Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a $0.17 dividend. The ex-dividend date is Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.35%. Genpact's payout ratio is 23.94%.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
